Your browser doesn't support javascript.
loading
Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes.
Kuemmerle-Deschner, Jasmin B; Hachulla, E; Cartwright, R; Hawkins, P N; Tran, T A; Bader-Meunier, B; Hoyer, J; Gattorno, M; Gul, A; Smith, J; Leslie, K S; Jiménez, S; Morell-Dubois, S; Davis, N; Patel, N; Widmer, A; Preiss, R; Lachmann, H J.
Afiliação
  • Kuemmerle-Deschner JB; Division of Pediatric Rheumatology, Department of Pediatrics, University Hospital Tübingen, Germany. kuemmerle.deschner@uni-tuebingen.de
Ann Rheum Dis ; 70(12): 2095-102, 2011 Dec.
Article em En | MEDLINE | ID: mdl-21859692
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-1beta / Síndromes Periódicas Associadas à Criopirina / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Humans / Middle aged Idioma: En Ano de publicação: 2011 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Interleucina-1beta / Síndromes Periódicas Associadas à Criopirina / Anticorpos Monoclonais Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Humans / Middle aged Idioma: En Ano de publicação: 2011 Tipo de documento: Article